Answer
Ziihera (zanidatamab) is contraindicated in patients with hypersensitivity to zanidatamab or any excipient listed in section 6.1.
Sources for this answer
- Ziihera 300 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Research UK Limited · emc · SmPC §4.3 Contraindications · Version 3Document updated
Sources checked